June 1, 2026: More Lawsuits Filed in GLP-1 Litigation as Eli Lilly Asks for Lawsuit Dismissal The company that makes Trulicity, Eli Lilly, has asked for lawsuits in the GLP-1 to be dismissed and asked for testimonies from plaintiffs experts to be excluded
Emerging Safety Concerns and Mortality Data from Weight Loss and Diabetes Medications Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as Mounjaro (tirzepatide), Wegovy and Ozempic (semaglutide), and Saxenda (liraglutide) have surged in popularity for both type 2 diabetes management and weight loss
Insulin action and resistance in obesity and type 2 diabetes
The apparatus and testing paradigm was previously described in (64)
Si tratta di molecole che imitano lazione di ormoni intestinali naturali le incretine coinvolti nella regolazione della glicemia, dellappetito e del metabolismo energetico
GLP-1 stands for glucagon-like peptide-1, a hormone your body naturally produces after eating